Pneumocystis-associated organizing pneumonia as a manifestation of immune reconstitution inflammatory syndrome in an HIV-infected individual with a normal CD4+ T-cell count following antiretroviral therapy

International Journal of STD and AIDS

Volumn 20, Issue 9, 2009, Pages 662-665

  Mori, S ^a   Polatino, S ^a   Estrada Y Martin, R M ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

HAART; HIV; IRIS; Organizing pneumonia; Pneumocystis

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; COTRIMOXAZOLE; EFAVIRENZ; EMTRICITABINE; TENOFOVIR; VIRUS RNA;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHUS BIOPSY; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; DYSPNEA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LUNG LAVAGE; MALE; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; THORAX RADIOGRAPHY; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; PNEUMONIA, PNEUMOCYSTIS;

EID: 69949138888     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008428     Document Type: Article

References (19)

1. Wachter RM, Luce JM. Respiratory failure from severe Pneumocystis carinii pneumonia. Entering the third era. Chest 1994;106:1313-1315
2. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998;352:1725-1730 (Pubitemid 28534954)
3. Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis 2006;42:1639-1646 (Pubitemid 43752655)
4. Torre D, Speranza F, Martegani R. Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection. HIV Med 2005;6:66-78 (Pubitemid 40425970)
5. Blanche P, Gombert B, Ginsburg C, et al. HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy. Scand J Infect Dis 1998;30:615-616 (Pubitemid 29145755)
6. Carr A, Cooper DA. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor. Lancet 1997;349:995-996 (Pubitemid 27149806)
7. Race EM, Adelson-Mitty J, Kriegel GR, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998;351:252-255 (Pubitemid 28043950)
8. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002;359:2059-2064 (Pubitemid 34680968)
9. Imami N, Hardy G, Pires A, et al. Immune reconstitution in HIV-1-infected patients. Curr Opin Investig Drugs 2002;3:1138-1145
10. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006;42:418-427 (Pubitemid 43122323)
11. Manabe YC, Campbell JD, Sydnor E, Moore RD. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007;46:456-462 (Pubitemid 350098697)
12. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000;133:447-454
13. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 2007;7:395-401 (Pubitemid 46765196)
14. Barry SM, Lipman MC, Deery AR, Johnson MA, Janossy G. Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Med 2002;3:207-211 (Pubitemid 34905553)
15. Godoy MC, Silva CI, Ellis J, Phillips P, Muller NL. Organizing pneumonia as a manifestation of Pneumocystis jiroveci immune reconstitution syndrome in HIV-positive patients: report of 2 cases. J Thorac Imaging 2008;23:39-43
16. Wachter RM, Flanders SA, Fee C, Pronovost PJ. Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure. Ann Intern Med 2008;149:29-32 (Pubitemid 351931130)
17. Breton G, Duval X, Estellat C, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004;39:1709-1712 (Pubitemid 39578550)
18. Drakopanagiotakis F, Polychronopoulos V, Judson MA. Organizing pneumonia. Am J Med Sci 2008;335:34-39
19. Lederman MM. Immune restoration and CD4+ T-cell function with antiretroviral therapies. AIDS 2001;15(Suppl. 2):S11-5